Variations in C-reactive protein during a single haemodialysis session do not associate with mortality

Area of Science:

• Nephrology
• Clinical Chemistry
• Biomarkers

Background:

• Elevated C-reactive protein (CRP) during hemodialysis (HD) has been linked to mortality.
• Existing understanding of CRP metabolism struggles to explain these short-term increases.
• This study investigates the relationship between CRP changes during HD and patient outcomes.

Purpose of the Study:

• To determine if changes in C-reactive protein (CRP) levels during a single hemodialysis (HD) session are associated with mortality.
• To investigate the reliability of CRP as a short-term mortality predictor in HD patients.
• To assess the biological plausibility of CRP increases within a single HD session.

Main Methods:

• CRP levels were measured pre- and post-hemodialysis in 190 Swedish (MIMICK cohort) and 94 Dutch (NECOSAD) HD patients.
• Patient mortality and censoring events were recorded during follow-up.
• Hazard ratios were calculated to analyze the association between CRP variation and mortality; concordance of CRP changes was assessed.

Main Results:

• Mean CRP levels did not significantly increase during a single HD session in either cohort.
• No statistically significant association was found between CRP changes during HD and mortality in crude or adjusted analyses in both cohorts.
• Concordance in CRP changes across multiple dialysis sessions for the same individuals was poor.

Conclusions:

• Changes in C-reactive protein (CRP) during a single hemodialysis (HD) session are not associated with mortality.
• The findings contribute to biological uncertainty regarding the capacity for CRP to rise significantly within the short timeframe of an HD session.
• CRP's utility as a short-term mortality biomarker in the context of hemodialysis requires further investigation.